Once-Monthly Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Hemodialysis-Dependent Chronic Kidney Disease: Pooled Data from Phase III Trials
Crossref DOI link: https://doi.org/10.1007/s12325-016-0309-6
Published Online: 2016-03-10
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Locatelli, Francesco
Choukroun, Gabriel
Truman, Matt
Wiggenhauser, Alfons
Fliser, Danilo
Funding for this research was provided by:
F. Hoffman-La Roche